Sino-High (China) Co., Ltd.

SZSE:301076 Rapport sur les actions

Capitalisation boursière : CN¥2.7b

Sino-High (China) Résultats passés

Passé contrôle des critères 2/6

Sino-High (China) has been growing earnings at an average annual rate of 4.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 9.6% per year. Sino-High (China)'s return on equity is 5.7%, and it has net margins of 15.8%.

Informations clés

4.2%

Taux de croissance des bénéfices

-3.4%

Taux de croissance du BPA

Chemicals Croissance de l'industrie12.1%
Taux de croissance des recettes9.6%
Rendement des fonds propres5.7%
Marge nette15.8%
Dernière mise à jour des bénéfices30 Sep 2024

Mises à jour récentes des performances passées

Sino-High (China)'s (SZSE:301076) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01
Sino-High (China)'s (SZSE:301076) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Recent updates

Sino-High (China) Co., Ltd.'s (SZSE:301076) P/E Is Still On The Mark Following 36% Share Price Bounce

Oct 09
Sino-High (China) Co., Ltd.'s (SZSE:301076) P/E Is Still On The Mark Following 36% Share Price Bounce

Some Sino-High (China) Co., Ltd. (SZSE:301076) Shareholders Look For Exit As Shares Take 28% Pounding

Apr 15
Some Sino-High (China) Co., Ltd. (SZSE:301076) Shareholders Look For Exit As Shares Take 28% Pounding

Sino-High (China)'s (SZSE:301076) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01
Sino-High (China)'s (SZSE:301076) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Should You Think About Buying Sino-High (China) Co., Ltd. (SZSE:301076) Now?

Feb 29
Should You Think About Buying Sino-High (China) Co., Ltd. (SZSE:301076) Now?

Ventilation des recettes et des dépenses

Comment Sino-High (China) gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

SZSE:301076 Recettes, dépenses et bénéfices (CNY Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Sep 24411653214
30 Jun 24415713615
31 Mar 24426783516
31 Dec 23435933315
30 Sep 234511053914
30 Jun 234451093715
31 Mar 234121073313
01 Jan 233981073113
30 Sep 22383883215
30 Jun 22364822813
31 Mar 22355712711
31 Dec 21342662811
30 Sep 21312652610
31 Dec 20288712710
31 Dec 19292742411
31 Dec 1826763289
31 Dec 1616535240
30 Sep 1617035240
30 Jun 1617635250
31 Mar 1616733250
31 Dec 1515830240
31 Dec 1414120190
31 Dec 13997130

Des revenus de qualité: 301076 has high quality earnings.

Augmentation de la marge bénéficiaire: 301076's current net profit margins (15.8%) are lower than last year (23.3%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: 301076's earnings have grown by 4.2% per year over the past 5 years.

Accélération de la croissance: 301076's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Bénéfices par rapport au secteur d'activité: 301076 had negative earnings growth (-38.2%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).


Rendement des fonds propres

ROE élevé: 301076's Return on Equity (5.7%) is considered low.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé